Publication:
Are all beta-blockers the same? nebivolol vasodilator properties and evidence for relevance in treatment of hypertension

Simple item page
dc.contributor.coauthorAfsar, Baris
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:18:13Z
dc.date.issued2015
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue1
dc.description.openaccessYES
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume17
dc.identifier.doi10.1111/jch.12447
dc.identifier.eissn1751-7176
dc.identifier.issn1524-6175
dc.identifier.scopus2-s2.0-84920982522
dc.identifier.urihttps://doi.org/10.1111/jch.12447
dc.identifier.urihttps://hdl.handle.net/20.500.14288/10351
dc.identifier.wos347835800006
dc.keywordsCentral aortic pressure
dc.keywordsCentral blood-pressure
dc.keywordsStiffness
dc.keywordsAugemntation
dc.keywordsDeterminants
dc.keywordsMetoprolol
dc.keywordsAtenolol
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofJournal Of Clinical Hypertension
dc.subjectPeripheral vascular disease
dc.titleAre all beta-blockers the same? nebivolol vasodilator properties and evidence for relevance in treatment of hypertension
dc.title.alternativeAre all β-blockers the same? Nebivolol vasodilator properties and evidence for relevance in treatment of hypertension
dc.typeOther
dc.type.otherEditorial material
dspace.entity.typePublication
local.contributor.kuauthorKanbay, Mehmet
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext